Webinars: Highly Multiplexed Single-Cell Proteomics Identifies Key Inflammatory Mediators in Severe COVID-19

Highly Multiplexed Single-Cell Proteomics Identifies Key Inflammatory Mediators in Severe COVID-19

Join Clinical Lab Manager and our panel of experts to learn more about how IsoPlexis technology can accelerate your current or future research projects

Watch On Demand

Photo portrait of Victor Tek
Victor Tek
Highly Multiplexed Single-Cell Proteomics Identifies Key Inflammatory Mediators in Severe COVID-19

In this webinar, IsoPlexis product manager Victor Tek discusses how researchers used IsoPlexis’ low volume highly multiplexed bulk proteomics (CodePlex) to investigate the role of airway and plasma immune cells in the pathogenesis of severe COVID-19. Learn more about how IsoPlexis technology can accelerate your current or future research projects.

Sponsor

Watch On Demand

Today's Clinical Lab

Today’s Clinical Lab is a reader-centric publication that keeps clinical professionals up to date with today’s rapidly changing lab industry with in-depth and timely editorial content and resources, including clinical industry news and insights into the latest trends, technologies, and techniques in the clinical lab.


Related Articles